A double-blind, randomized, placebo-controlled trial showed that in just 12 weeks, Superguts prebiotic fiber blend significantly improved blood sugar levels while supporting weight loss, digestion, and metabolic health in people with type 2 diabetes
Earlier dual-agonist research (combining GLP-1 with glucagon) had explored these benefits but was hampered by hyperglycemia
When CF1 mice and New Zealand rabbits were exposed to dichlorvos at an average actual concentration of 4 mg/m 3 for 7 h per day from days 6 to 15 and from days 6 to 18 of gestation, respectively, no significant effect on the mean number of live fetuses per litter, the incidence or distribution of resorptions, or on fetal body measurements was noted
What are the short-term side effects caused by GLP-1 medications
From 5 October 2018 to 1 February 2019, 304 participants were randomly assigned to semaglutide 2.4 mg ( n = 152) or placebo ( n = 152), 92.8% of whom completed the trial (attended the end-of-trial safety visit)
Most providers avoid this concentration for higher doses because of the large injection volumes involved
